Source: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Unidades: FM, ICB
Subjects: NEOPLASIAS PROSTÁTICAS, GENÉTICA APLICADA, BIOMARCADORES
ABNT
PIMENTA, Ruan Cesar Aparecido et al. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, v. 150, n. 2, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58730. Acesso em: 18 nov. 2024.APA
Pimenta, R. C. A., Malulf, F. C., Silva, P. R. da, Caetano, G. V. B., Silva, K. S. da, Nunes, V. G., et al. (2023). Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 150( 2). doi:10.1007/s00432-023-05598-xNLM
Pimenta RCA, Malulf FC, Silva PR da, Caetano GVB, Silva KS da, Nunes VG, Santos GAGD dos, Schreiter VRG, Silva IA da, Camargo JA de, Antunes AA, Srougi M, Nahas WC, Leite KRM. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression [Internet]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023 ; 150( 2):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58730Vancouver
Pimenta RCA, Malulf FC, Silva PR da, Caetano GVB, Silva KS da, Nunes VG, Santos GAGD dos, Schreiter VRG, Silva IA da, Camargo JA de, Antunes AA, Srougi M, Nahas WC, Leite KRM. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression [Internet]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023 ; 150( 2):[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58730